Are you curious about the potential therapeutic benefits of psychedelic-assisted therapy? Tune in to this week's episode of our podcast, where we have a fascinating conversation with Dr. Graham Campbell, a renowned consultant psychiatrist and researcher in the field.
Drawing from his extensive experience in both psychedelic research and clinical work, Dr. Campbell shares his insights on a range of topics. Discover his thoughts on the possibility of introducing psychedelic treatments by the NHS, the differences between magic mushrooms and DMT in the treatment of depression, and the crucial role of music in a psychedelic journey.
Join us for an engaging and informative discussion on the cutting-edge of psychedelic-assisted therapy, with one of the leading experts in the field. Don't miss out - listen to our latest episode now!
Listen to Graham's music here!
Psychedelic Assisted Therapy
Small Pharma
DMT
Ketamine
Intranasal Esketamine (SpravatoTM) for Use in Treatment-Resistant Depression In Conjunction With an Oral Antidepressant
Schizophrenia
Bipolar disorder
Schizoaffective disorder
Trial of Psilocybin versus Escitalopram for Depression
Rosalind Watts
Michelle Baker Jones
Roberta Murphy
Jonny Martell
Ashleigh Murphy-Beiner
Psilocybin
Institute of Psychedelic Therapy
The Readiness of Psychiatrists to Implement Psychedelic-Assisted Psychotherapy
Sussex Partnership NHS Foundation Trust
Ayahuasca
Monoamine oxidase inhibitor
Serotonin
The ACE Model
The hidden therapist: evidence for a central role of music in psychedelic therapy
Max Cooper
Music and the Mind by Anthony Storr
Mind Foundation
Maria Papaspyrou
★ Support this podcast ★